Sellas Life Sciences Group Inc
General ticker "SLS" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $70.7M
Sellas Life Sciences Group Inc follows the US Stock Market performance with the rate: 22.2%.
Estimated limits based on current volatility of 4.3%: low 0.87$, high 0.95$
Factors to consider:
- Price in estimated range
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [0.65$, 1.94$]
- 2024-12-30 to 2025-12-30 estimated range: [0.72$, 2.01$]
Financial Metrics affecting the SLS estimates:
- Negative: Non-GAAP EPS, $ of -1.36 <= 0.10
- Negative: Operating profit margin, % of -100 <= 1.03
- Negative: Operating cash flow per share per price, % of -51.08 <= 2.35
- Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85
- Positive: -0.96 < Investing cash flow per share, $ of -0.20
- Negative: negative Net income
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Positive: Inventory ratio change, % of 0 <= 0
Short-term SLS quotes
Long-term SLS plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $7.60MM | $1.00MM | $0.00MM |
| Operating Expenses | $32.89MM | $42.95MM | $37.87MM |
| Operating Income | $-25.29MM | $-41.95MM | $-37.87MM |
| Non-Operating Income | $4.36MM | $0.65MM | $0.53MM |
| R&D Expense | $21.37MM | $30.27MM | $24.01MM |
| Income(Loss) | $-20.94MM | $-41.30MM | $-37.34MM |
| Taxes | $-0.24MM | $-0.65MM | $0.00MM |
| Profit(Loss) | $-20.70MM | $-40.65MM | $-37.34MM |
| Stockholders Equity | $20.35MM | $4.85MM | $-7.98MM |
| Assets | $26.27MM | $20.94MM | $6.22MM |
| Operating Cash Flow | $-26.02MM | $-23.81MM | $-31.41MM |
| Capital expenditure | $0.00MM | $4.50MM | $5.50MM |
| Investing Cash Flow | $0.00MM | $-4.50MM | $-5.50MM |
| Financing Cash Flow | $12.07MM | $24.08MM | $22.32MM |
| Earnings Per Share* | $-1.34 | $-2.10 | $-1.34 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.